- Home
- RVPHW vs CNXN Comparison
RVPHW vs CNXN Comparison
Compare RVPHW & CNXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPHW
- CNXN
- Stock Information
- Founded
- RVPHW N/A
- CNXN 1982
- Country
- RVPHW United States
- CNXN United States
- Employees
- RVPHW 15
- CNXN N/A
- Industry
- RVPHW Biotechnology: Pharmaceutical Preparations
- CNXN Catalog/Specialty Distribution
- Sector
- RVPHW Health Care
- CNXN Consumer Discretionary
- Exchange
- RVPHW Nasdaq
- CNXN Nasdaq
- Market Cap
- RVPHW N/A
- CNXN 1.9B
- IPO Year
- RVPHW 2018
- CNXN 1998
- Fundamental
- Price
- RVPHW $0.14
- CNXN $69.00
- Analyst Decision
- RVPHW
- CNXN
- Analyst Count
- RVPHW 0
- CNXN 0
- Target Price
- RVPHW N/A
- CNXN N/A
- AVG Volume (30 Days)
- RVPHW N/A
- CNXN 81.1K
- Earning Date
- RVPHW N/A
- CNXN 02-12-2025
- Dividend Yield
- RVPHW N/A
- CNXN 0.58%
- EPS Growth
- RVPHW N/A
- CNXN 14.84
- EPS
- RVPHW N/A
- CNXN 3.40
- Revenue
- RVPHW N/A
- CNXN $2,789,687,000.00
- Revenue This Year
- RVPHW N/A
- CNXN $0.71
- Revenue Next Year
- RVPHW N/A
- CNXN $5.15
- P/E Ratio
- RVPHW N/A
- CNXN $20.30
- Revenue Growth
- RVPHW N/A
- CNXN N/A
- 52 Week Low
- RVPHW N/A
- CNXN $57.47
- 52 Week High
- RVPHW N/A
- CNXN $77.19
- Technical
- Relative Strength Index (RSI)
- RVPHW N/A
- CNXN 37.90
- Support Level
- RVPHW N/A
- CNXN $70.07
- Resistance Level
- RVPHW N/A
- CNXN $75.08
- Average True Range (ATR)
- RVPHW 0.00
- CNXN 1.94
- MACD
- RVPHW 0.00
- CNXN -0.53
- Stochastic Oscillator
- RVPHW 0.00
- CNXN 2.22
About RVPHW Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
About CNXN PC Connection Inc.
PC Connection Inc is a provider of information technology solutions. It provides products such as computer systems, software and peripheral equipment, networking communications, and other products and accessories that company purchase from manufacturers and distributors. The company also offers services involving design, configuration, and implementation of IT solutions. It conducts business operations through three business segments namely Connection Business Solutions, Connection Enterprise Solutions, and Connection Public Sector Solutions. The company generates maximum revenue Connection Enterprise Solutions segment.